Accurate grading of patients with neuroendocrine neoplasms (NENs) is essential for risk
stratification and optimal choice of therapy. Currently, grading is based on histologically …

Accurate grading of patients with neuroendocrine neoplasms (NENs) is essential for risk
stratification and optimal choice of therapy. Currently, grading is based on histologically …

The objective of this retrospective study was to determine the role of 18F-FDG PET/CT in a
large cohort of 495 patients with metastatic neuroendocrine neoplasms (NENs) who were …

Purpose To determine the value of 68 Ga-DOTA-TOC and 18 F-FDG PET/CT for initial and
follow-up evaluation of patients with neuroendocrine tumour (NET) treated with peptide …

Prognostic Value of 18F-FDG PET in Neuroendocrine Neoplasm:... : Clinical Nuclear Medicine
Prognostic Value of 18F-FDG PET in Neuroendocrine Neoplasm: A Systematic Review and …

To date, limited data are available concerning peptide receptor radionuclide therapy (PRRT)
of grade 3 (G3) neuroendocrine neoplasms (NENs) with a Ki-67 proliferation index of …

Simple Summary Functional imaging with 18F-fluorodeoxyglucose positron emission
tomography (18F-FDG PET) has evolved into a major clinical tool in cancer diagnosis and …

The tumor proliferation marker, Ki-67 index, is a well-established prognostic marker in
gastroenteropancreatic neuroendocrine neoplasms (NENs). Noninvasive molecular imaging …

Purpose The prognostic value of FDG PET for neuroendocrine tumours (NETs) has been
reported. In this study we evaluated the role of FDG PET in predicting response and …

Management of patients with neuroendocrine neoplasms (NEN) is complex and warrants
referral of these patients to high volume centers with appropriate expertise to ensure …